Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Most people with type 1 diabetes do not appear to be at increased risk for hospitalization or death from COVID-19 compared to the general population, new research suggests.
Two retrospective studies of type 1 diabetes and COVID-19 were published in the October issue of Diabetes Care.
One, by Roman Vangoitsenhoven, MD, PhD, of University Hospitals Leuven, Belgium, and colleagues, found no evidence of increased hospitalization for COVID-19 among people with type 1 diabetes during the first 3 months of the pandemic in Belgium.
The other, from Maria Vamvini, MD, of the Joslin Diabetes Center, Boston, Massachusetts, and colleagues, showed that age and glycemic control didn't differ significantly between adults with type 1 diabetes hospitalized for COVID-19 and those hospitalized for other reasons.
Previous data from the UK Biobank and the Type 1 Diabetes (T1D) Exchange support these findings.
Altogether, these results suggest that although the risk for death from COVID-19 is higher overall among people with type 1 diabetes, that increased risk is mostly limited to a subset of particularly vulnerable patients, said Catarina Limbert, MD, PhD, during a press briefing at the virtual annual meeting of the European Association for the Study of Diabetes (EASD).
"Those with type 1 diabetes dying from COVID-19 were a specific population," stressed Limbert, of the University Center of Central Lisbon and Hospital Dona Estefania, Lisbon, Portugal.
"They had hemoglobin A1c levels above 10% and were over age 50 with a long diabetes duration. They were the more fragile, who couldn't survive the severity and aggressiveness of the virus. Good glucose control is a good sign and protective," she added.
Daniel Drucker, MD, of Mount Sinai Hospital, Toronto, Canada who spoke at the EASD press briefing regarding potential mechanisms involved in COVID-19 morbidity in diabetes reiterated the importance of glycemic control.
He showed a slide with the following advice for patients with both types of diabetes during the pandemic in addition to the general and now-familiar physical distancing, personal hygiene, hand washing, and wearing of masks:
Prepare a list of all medications, written and on the phone.
Consider supplies of medications, test strips, and continuous glucose monitoring equipment.
Don't neglect exercise, diet, and blood glucoseand blood pressure control.
Use telemedicine and devices to communicate with healthcare professionals.
Maintain appropriate levels of hydration, exercise, and glucose and ketone monitoring.
Optimize glycemic control whenever possible.
In hospitalized patients with type 2 diabetes, medications may need adjustment. Insulin is often the preferred glucose-lowering prescription.
In the Belgian study, medical records were analyzed for a total of 2336 patients with type 1 diabetes who received care at two specialist diabetes centers. The hospital admission rate was compared with national population data.
Overall, 0.21% (n = 5) of the patients with type 1 diabetes were admitted to the hospital with COVID-19, similar to the 0.17% (n = 15,239) of the general population, as of April 30, 2020 (P = .76).
During the same period, 127 individuals with type 1 diabetes were hospitalized for reasons other than COVID-19, including poor glycemic control (22%), diabetic ketoacidosis (8%), planned surgery (21%), diabetic foot problems (5%), and delivery (5%).
"It is noteworthy that the number of hospitalizations for reasons other than COVID-19 exceeded by far the number of COVID-19related hospitalizations," Vangoitsenhoven and colleagues write.
"Interpretation of adverse outcomes of people with type 1 diabetes during the COVID-19 epidemic should therefore be performed cautiously, as overinterpretation of the impact of COVID-19 itself on adverse outcomes in people with type 1 diabetes is likely," they conclude.
The Boston study, which was smaller, involved retrospective chart reviews of seven patients with type 1 diabetes hospitalized with COVID-19 and another 28 patients hospitalized for other reasons, all during the period from March to May 2020. The groups didn't differ in outpatient insulin doses corrected for weight or in glycemic control in the months preceding admission.
Diabetic ketoacidosis (DKA) occurred in one patient with COVID-19 and in two of the non-COVID patients. Both groups had significant preexisting diabetes-related complications, including nephropathy in more than half of each group and receipt of an organ transplant with immunosuppression in 14% of each group.
The composite outcome intensive care unit (ICU) admission, intubation, or death occurred in two COVID-19 patients (both cases involved ICU admission without intubation, and both patients recovered) and in four non-COVID patients, of whom two died.
The two groups showed "remarkable" similarity in age and glycemic control, although the COVID-19 patients were more likely to be Black (four vs two), consistent with other retrospective studies.
None of the patients had new-onset type 1 diabetes, which contrasts with the 15% seen in the T1D Exchange study.
Just 1 of the 7 patients with COVID-19 (14%) had DKA, compared with 30% of the confirmed and probable COVID-19 patients in the T1D Exchange study.
The significant difference in age about 52 years in the current study vs 21 years in the T1D Exchange study might explain those differences, Vamvini and colleagues say.
Limbert has received grants and personal fees from Abbott, Ipsen, and Sanofi. Vangoitsenhoven has disclosed no relevant financial relaitonships. Vamvini was supported by the National Institute of Diabetes and Digestive and Kidney Diseases. Drucker receives research support, consulting fees, and/or lecture fees from Novo Nordisk, Merck, Pfizer, and Intarcia.
Diabetes Care. 2020 Oct;43:e118-e119. Vangoitsenhoven et al, Full text; 2020 Oct;43:e120-e122. Vamvini et al, Full text
For more diabetes and endocrinology news, follow us on Twitter and Facebook.
The rest is here:
Emerging Data on Type 1 Diabetes and COVID-19 Reassuring - Medscape
- Novo Nordisk Isn't in The "Magnificent Seven," but Here's Why I Think It Should Be - Yahoo Finance - March 18th, 2024
- Doctor warns of strange telltale sign of diabetes which can appear on the legs - The Mirror - March 18th, 2024
- Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies - News-Medical.Net - March 18th, 2024
- Popular diabetes and weight loss drugs often hard to get for people who need them - NBC News - March 18th, 2024
- Your Health Matters: The ABCs of diabetes - The Globe | News, weather, sports from Worthington, Minnesota - The Globe - March 18th, 2024
- The Link Between Pancreatic Cancer and Diabetes - Cedars-Sinai - March 18th, 2024
- Nikita Kuzmin diabetes: what was he holding in the CBB house? - Cosmopolitan UK - March 18th, 2024
- FDA Approves Rezdiffra, the First Drug for Diabetes-Related Liver Disease - diaTribe Foundation - March 18th, 2024
- He took up running rather than take diabetes medication. It worked - South China Morning Post - March 18th, 2024
- Can Eating Yogurt Really Reduce Your Risk of Diabetes? - Health.com - March 18th, 2024
- Even short periods of diabetes remission are linked to lower risk of heart attack and stroke - The BMJ - March 18th, 2024
- Kidney stone risk factors and how type 2 diabetes medication may help - WECT - March 18th, 2024
- 'Making the Invisible Visible': CGMs Offer Insights for T2D - Medscape - March 18th, 2024
- Novo Nordisk Discontinues Insulin Medication After Cutting Its Price - The American Prospect - March 18th, 2024
- Infographic: Where GLP-1s Work Now -- and What's Coming - Medscape - March 18th, 2024
- Intermountain Health Experts Say Education Key to Prevention of Type 2 Diabetes | PRUnderground - PR Underground - March 18th, 2024
- International body recommends more sensitive test to indicate risk of developing diabetes - The Hindu - March 18th, 2024
- The importance of knowing your A1C level - KSAT San Antonio - March 18th, 2024
- Tandem Diabetes Care's t:slim X2 Insulin Pump is the First Automated Insulin Delivery System to Integrate with ... - Business Wire - January 9th, 2024
- Diffuse Alveolar Hemorrhage Occurring Suddenly in a Diabetic Patient With Asthma Exacerbation - Cureus - January 9th, 2024
- Virginia Tech researchers find drugs used to treat Type 2 diabetes reduce alcohol cravings - WRIC ABC 8News - January 9th, 2024
- FDA looking into reports of hair loss, suicidal thoughts in people using popular drugs for diabetes and weight loss - CNN - January 9th, 2024
- Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to ... - Cardiovascular Diabetology - January 9th, 2024
- Insulin price cap: More Americans will now pay no more than $35 - USA TODAY - January 9th, 2024
- Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for cosmetic reasons instead of for diabetes and obesity - Fortune - January 9th, 2024
- No Increased Risk of Suicidal Ideation With GLP-1 Drugs - Medpage Today - January 9th, 2024
- Ask the Doctors | New research being conducted to treat diabetes - Eureka Times-Standard - January 9th, 2024
- Salivary Chloride Intracellular Channel 1 (CLIC1) as a Hub of Gene-Gene Interactome of Periodontitis With Diabetes ... - Cureus - January 9th, 2024
- Why Omada's CEO Thinks Amazon Selected His Startup as the 1st Partner for Its New Program - MedCity News - January 9th, 2024
- Researchers find drugs used to treat type 2 diabetes and obesity reduce alcohol cravings - Medical Xpress - January 9th, 2024
- Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different ... - Nature.com - January 9th, 2024
- CV Safety Profile of TheracosBio's BRENZAVVY (bexagliflozin) Confirmed in Research Published in Diabetes ... - Business Wire - January 9th, 2024
- 6 "Bad" Fruits You Should Be Eating When You Have Diabetes, According to Dietitians - EatingWell - January 9th, 2024
- Children of Women with Type 1 Diabetes Have Increased Heart Defect Risk - Inside Precision Medicine - January 9th, 2024
- Transforming Corporate Health: Fitterfly's Success in Tackling Diabetes and Weight Issues - Business Standard - January 9th, 2024
- Ozempic and weight loss | News and views - Diabetes UK - January 9th, 2024
- Drugs used to treat Type 2 diabetes reduce alcohol cravings - ScienceBlog.com - January 9th, 2024
- People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds - ABC News - January 9th, 2024
- For Those With Diabetes On Medicare Part D, Insulin Is $35...If Its Covered - Forbes - October 27th, 2023
- Biologist Douglas Melton: I was studying frogs until my son was diagnosed with diabetes then I started looking for a cure - EL PAS USA - October 27th, 2023
- Diabetes and Hearing Loss with Concept by Iowa Hearing | Paid Content - Local 5 - weareiowa.com - May 9th, 2023
- COUNTY COLUMN: Learn to Live well with diabetes at The Well - Norman Transcript - May 1st, 2023
- Want to Cut Type 2 Diabetes Risk? This High-fat Food Can Be the Answer, According to New Study - Revyuh - May 1st, 2023
- Diabetes: What It Is, Causes, Symptoms, Treatment & Types - March 13th, 2023
- A number of healthtech startups claim they can reverse Type 2 diabetes. But caveats apply, caution doctors - Economic Times - March 13th, 2023
- Tampa doctor who lost brother to diabetes calls insulin price cut a 'game changer' - ABC Action News Tampa Bay - March 5th, 2023
- New study suggest people previously infected with COVID-19 could have increased risk for diabetes - CBS Los Angeles - February 16th, 2023
- Diabetes Symptoms, Causes, & Treatment | ADA - October 15th, 2022
- A nutritionist with type 1 diabetes shares the top 5 'food swaps' she eats to manage her blood sugar - CNBC - October 15th, 2022
- Diabetes and the gut: How a bacterial protein may impact insulin - Medical News Today - October 15th, 2022
- Milton teen involved in launch of diabetes support program - Milton Daily Standard - October 15th, 2022
- Providers Now Have Free Access to Latest Diabetes Technology in One Place - PR Newswire - October 15th, 2022
- 5 Modifiable Factors in Women with History of Gestational Diabetes Mellitus That Can Reduce the Risk of T2D - Pharmacy Times - October 15th, 2022
- BCMH the stoy of Diabetes and Determination - 921News - October 15th, 2022
- Can skipping a meal lead to diabetes and fat around abdomen? - The Indian Express - October 15th, 2022
- Type 2 Diabetes Drugs Market Research Report by Drug, Application, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 -... - October 15th, 2022
- Diabetes: Symptoms, risks, and prevention - Wilmington News Journal, OH - July 17th, 2022
- Diabetes symptoms: The sign of nerve damage that often strikes at night - severe - Express - July 17th, 2022
- Local Teen Brings Smiles and Health Kits to Kids with Diabetes - River Journal Staff - July 17th, 2022
- Type 3 diabetes: symptoms, causes and treatments - Livescience.com - July 17th, 2022
- Diabetes Travel Essentials and Tips for the Approximately 21 Million Americans that Must Manage Their Diabetes While on Vacation - PR Newswire - July 17th, 2022
- A type of 'step therapy' is an effective strategy for diabetic eye disease - National Institutes of Health (.gov) - July 17th, 2022
- Diabetes education: one in five search results for diabetes lack reliable information - Open Access Government - July 17th, 2022
- Arch City Kids Theater Troupe Fights Type 1 Diabetes With Its Annual Revue - Broadway World - July 17th, 2022
- Nutrigenomics Testing Industry Forecast to 2027 - Insights Into Obesity, Diabetes, Cancer, and Cardiovascular Disease Applications -... - July 17th, 2022
- Harvard Scientists Have Developed a Revolutionary New Treatment for Diabetes - SciTechDaily - June 16th, 2022
- Do Viruses and Coxsackievirus Cause Type 1 Diabetes? - Healthline - June 16th, 2022
- Diabetes Week: Types 1 and 2 symptoms, causes and prevention - Yahoo Entertainment - June 16th, 2022
- Diabetes And Sex: Have Safe Sex While Managing Diabetes - MadameNoire - June 16th, 2022
- Diabetes Devices Market to Expand at the CAGR of 6.4% from 2019 to 2027, Increase in Prevalence of Diabetes Expected to Drive Global Market - BioSpace - June 16th, 2022
- Anemia and Diabetes: What You Should Know - Healthline - June 16th, 2022
- Patient Knowledge of Diabetes and CKD in an Inner-City Population - DocWire News - June 16th, 2022
- ASCENSIA DIABETES CARE ANNOUNCES EUROPEAN APPROVAL OF THE NEXT-GENERATION EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM - PR Newswire - June 16th, 2022
- Understanding the Link between Diabetes Care and Sickle Cell Disease | NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases... - June 16th, 2022
- Child type 2 diabetes referrals in England and Wales jump 50% amid obesity crisis - The Guardian - June 16th, 2022
- Covenant Childrens to host diabetes camp in July - KLBK | KAMC | EverythingLubbock.com - June 16th, 2022
- Pattern of contraceptive use among reproductive-aged women with diabetes and/or hypertension: findings from Bangladesh Demographic and Health Survey -... - June 16th, 2022
- Diabetes warning: The 6 signs on your SKIN that can be a sign of life-threatening disease... - The Sun - June 16th, 2022
- www.thestreet.com - December 8th, 2021
- Long-Term Glycemic Control Cuts Risk for Severe COVID-19 With T2DM - HealthDay News - December 8th, 2021